NEUROCRINE BIOSCIENCES INC filings

SEC filings by NEUROCRINE BIOSCIENCES INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-13VANGUARD GROUP INCNEUROCRINE BIOSCIENCES INC9,710,3289.9%EDGAR
SC 13G/A2024-01-23BlackRock Inc.NEUROCRINE BIOSCIENCES INC13,647,67913.9%EDGAR
SC 13D/A2023-02-24NEUROCRINE BIOSCIENCES INCVoyager Therapeutics, Inc.8,575,31619.9%EDGAR
SC 13G/A2023-02-09VANGUARD GROUP INCNEUROCRINE BIOSCIENCES INC9,340,2959.7%EDGAR
SC 13G/A2023-02-09JANUS HENDERSON GROUP PLCNEUROCRINE BIOSCIENCES INC2,415,6382.5%EDGAR
SC 13G/A2023-01-23BlackRock Inc.NEUROCRINE BIOSCIENCES INC12,627,40313.1%EDGAR
SC 13G/A2022-02-14PRICE T ROWE ASSOCIATES INC /MD/NEUROCRINE BIOSCIENCES INC4,359,6454.5%EDGAR
SC 13G/A2022-02-10VANGUARD GROUP INCNEUROCRINE BIOSCIENCES INC8,787,9919.3%EDGAR
SC 13G/A2022-02-10JANUS HENDERSON GROUP PLCNEUROCRINE BIOSCIENCES INC7,445,8397.8%EDGAR
SC 13G/A2022-01-27BlackRock Inc.NEUROCRINE BIOSCIENCES INC11,476,54512.1%EDGAR
SC 13G/A2022-01-26BlackRock Inc.NEUROCRINE BIOSCIENCES INC11,476,54512.1%EDGAR
SC 13G/A2021-08-10FMR LLCNEUROCRINE BIOSCIENCES INC3,780,0764.0%EDGAR
SC 13G/A2021-04-12BlackRock Inc.NEUROCRINE BIOSCIENCES INC10,989,64611.7%EDGAR
SC 13G/A2021-04-12JANUS HENDERSON GROUP PLCNEUROCRINE BIOSCIENCES INC9,444,12110.0%EDGAR
SC 13G/A2021-02-16PRICE T ROWE ASSOCIATES INC /MD/NEUROCRINE BIOSCIENCES INC6,271,7306.7%EDGAR
SC 13G/A2021-02-16Capital International InvestorsNEUROCRINE BIOSCIENCES INC4,049,4424.3%EDGAR
SC 13G/A2021-02-11JANUS HENDERSON GROUP PLCNEUROCRINE BIOSCIENCES INC9,307,9209.9%EDGAR
SC 13G/A2021-02-10VANGUARD GROUP INCNEUROCRINE BIOSCIENCES INC8,337,2658.9%EDGAR
SC 13G/A2021-02-08FMR LLCNEUROCRINE BIOSCIENCES INC8,436,6299.0%EDGAR
SC 13G/A2021-01-29BlackRock Inc.NEUROCRINE BIOSCIENCES INC6,997,7957.5%EDGAR